China's State Medical Insurance Administration announced 18 cancer drugs that will be included in 2018 medical insurance access negotiations. Companies with drugs on the list will now enter into negotiations to include the drugs on the country's National Reimbursement Drug List (NRDL).
The agency, which launched in May, is responsible
